Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001209191-20-057030

10% owner bought 333,333 shares at $15.00 ($4,999,995)

  • 10% owner acquired 2,164,458 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novo Holdings A/S 10% owner 2020-11-02 Conversion +2,164,458 2,164,458 D
Novo Holdings A/S 10% owner 2020-11-02 Purchase +333,333 $15.00 $4,999,995 2,497,791 D
Derivatives
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES B-1 PREFERRED STOCK −25,562 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES B-2 PREFERRED STOCK −15,833 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES B-3 PREFERRED STOCK −63,333 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES B-4 PREFERRED STOCK −66,666 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES C-1 PREFERRED STOCK −133,991 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES C-2 PREFERRED STOCK −194,666 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES C-4 PREFERRED STOCK −181,688 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES C-5 PREFERRED STOCK −51,911 0 D
Novo Holdings A/S 10% owner 2020-11-02 Conversion · SERIES D PREFERRED STOCK −98,930 0 D
Open-market purchases · 333,333 sh · avg $15.00 · $4,999,995
Loading xslF345X03/doc4.xml…